Back

Subcutaneous ICD therapy results in a similar quality of life compared with transvenous ICD therapy during both short- and long-term follow-up

16 April 2023 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Device Therapy - ICD Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2023

About the speaker

Photo
Ms Jolien Anne De Veld

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

8 More presentations in this session

Presentation thumbnail
ICD patients with first appropriate ICD shock: new treatment concept is associated with better outcome
Doctor T. Kleemann (Ludwigshafen, DE)
Abstract Slides
Presentation thumbnail
Automatic subcutaneous defibrillator screening in patients with intracardiac devices: comparative study depending on the point of pacing
Doctor E. Cabrera Borrego (Granada, ES)
Abstract Slides
Presentation thumbnail
A manual synchronous low energy shock impedance as a predictor of successful defibrillation testing during subcutaneous icd implantation.
Doctor C. Lopez Perales (Zaragoza, ES)
Abstract Slides
Presentation thumbnail
Clinical predictors of very low defibrillation threshold in the extravascular ICD
Doctor F. Murgatroyd (London, GB)
Abstract Slides
Presentation thumbnail
The last shall be the first: the role of combined QLV- and CMR-determined electromechanical concordance in predicting optimal left ventricular stimulation site in cardiac resynchronisation therapy.
Doctor M. Bertelli (Bologna, IT)
Abstract Slides

Access the full session

Session thumbnail
Device Therapy - ICD

The Event

Event poster

EHRA 2023

16 April - 18 April 2023
You may be interested in
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Session
Debate on primary prevention in ICD therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources